NGL Fine-Chem Ltd. (NGLFINE) AI Stock Analysis

• Market Cap: ₹9.41B
• Dividend Yield: 0.11%
• Average Volume (3M): 156.00
• Price to Earnings (P/E): 44.6
• Beta (1Y): 0.91
• Revenue Growth: 6.44%
• EPS Growth: -50.37%
• Country: IN
• Employees: 682
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Drug Manufacturers - General
• EPS (TTM): 14.96
• Shares Outstanding: 6,178,024
• 10 Day Avg. Volume: 192
• 30 Day Avg. Volume: 156
• PEG Ratio: -0.68
• Price to Book (P/B): 2.47
• Price to Sales (P/S): 1.89
• P/FCF Ratio: -7.35
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹1,439.00
• Price Target Upside: -4.45% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 65 Neutral
• Price Target: ₹1,439.00 ▼(-4.45% Downside)

NGL Fine-Chem Ltd. has a solid growth trajectory with strong revenue and equity growth, but faces challenges in profitability and cash flow management. The stock shows positive technical momentum, but its high valuation and low dividend yield are concerns for value-focused investors.

NGL Fine-Chem Ltd. Business Overview & Revenue Model

Company Description

NGL Fine-Chem Ltd. (NGLFINE) is a leading manufacturer and supplier in the fine chemicals sector, specializing in high-quality intermediates and specialty chemicals for various industries including pharmaceuticals, agrochemicals, and specialty coatings. The company is committed to innovation and sustainability, producing a range of products that meet stringent quality standards and regulatory requirements. NGL Fine-Chem operates on a global scale, catering to a diverse clientele with tailored solutions that enhance their operational efficiency and product performance.

How the Company Makes Money

NGL Fine-Chem Ltd. generates revenue primarily through the production and sale of fine chemicals and intermediates. The company's revenue model is based on direct sales to manufacturers in the pharmaceutical and agrochemical industries, as well as partnerships with distributors that help extend its market reach. Key revenue streams include contract manufacturing for customized chemical solutions, bulk sales of specialty chemicals, and long-term supply agreements with major industry players. Additionally, NGLFINE benefits from collaborations with research institutions and universities, which not only enhance its product development but also open up new markets and revenue opportunities. The company's focus on R&D and innovation ensures a steady pipeline of new products that can cater to evolving market demands, thereby contributing significantly to its earnings.

NGL Fine-Chem Ltd. Financial Statement Overview

Summary

NGL Fine-Chem Ltd. shows strong revenue growth and a stable equity position, essential for long-term sustainability. However, challenges in profitability and cash flow management, such as declining Net Income and negative Free Cash Flow, along with increased leverage, pose potential risks.

Income Statement

NGL Fine-Chem Ltd. has demonstrated robust revenue growth over the years, with a significant increase in Total Revenue from 2020 to 2025. The Gross Profit Margin and Net Profit Margin have shown variability, reflecting fluctuations in cost management and profitability. Although the recent year saw a decline in Net Income, the company's EBIT Margin and EBITDA Margin, while varying, indicate a stable operational performance. Overall, the income statement suggests a growing company with solid revenue but facing profitability challenges in recent years.

Balance Sheet

The balance sheet of NGL Fine-Chem Ltd. reflects a stable equity base with Stockholders' Equity consistently increasing. However, the Debt-to-Equity Ratio has risen recently, indicating increased leverage. The Equity Ratio remains healthy, suggesting a strong equity foundation. Return on Equity (ROE) has been inconsistent, indicating variable profitability relative to shareholders' investments. Overall, the balance sheet shows strengths in equity growth but reveals potential risks due to increasing leverage.

Cash Flow

The cash flow analysis reveals challenges in generating free cash flow, as evidenced by negative Free Cash Flow in recent periods. Operating Cash Flow has seen growth but not at a pace to offset high capital expenditures. The Free Cash Flow to Net Income Ratio indicates inefficiencies in converting profits into free cash flow. Overall, the cash flow statement highlights a need for improved cash management and cost control measures.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.82B	3.68B	3.39B	2.78B	3.18B	2.58B
Gross Profit	1.94B	1.86B	1.70B	1.38B	1.66B	1.53B
EBITDA	450.78M	338.69M	678.69M	404.87M	788.78M	881.27M
Net Income	208.74M	211.24M	413.17M	204.96M	498.97M	567.19M
Balance Sheet
Total Assets	0.00	4.33B	3.56B	2.87B	2.77B	2.08B
Cash, Cash Equivalents and Short-Term Investments	655.28M	655.28M	553.14M	525.02M	295.49M	338.51M
Total Debt	0.00	731.53M	340.04M	324.99M	300.01M	164.48M
Total Liabilities	-2.82B	1.51B	929.04M	645.30M	737.10M	533.08M
Stockholders Equity	2.82B	2.82B	2.63B	2.23B	2.03B	1.54B
Cash Flow
Free Cash Flow	0.00	-949.49M	-80.59M	38.80M	-425.52M	101.42M
Operating Cash Flow	0.00	358.22M	204.65M	352.86M	138.25M	273.54M
Investing Cash Flow	0.00	-345.53M	-268.17M	-270.20M	-142.03M	-245.68M
Financing Cash Flow	0.00	-10.81M	-10.81M	-10.81M	-10.81M	-10.81M

NGL Fine-Chem Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1506.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NGLFINE, the sentiment is Positive. The current price of 1506 is above the 20-day moving average (MA) of 1463.87, above the 50-day MA of 1420.16, and above the 200-day MA of 1305.49, indicating a bullish trend. The MACD of 30.47 indicates Negative momentum. The RSI at 56.34 is Neutral, neither overbought nor oversold. The STOCH value of 60.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:NGLFINE.

NGL Fine-Chem Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NGLFINE	65 Neutral	₹9.41B	44.57	―	0.11%	6.44%	-50.37%
GANESHBE	65 Neutral	₹6.25B	15.76	―	―	-13.61%	-38.45%
INDOBORAX	65 Neutral	₹7.45B	19.26	―	0.43%	-3.77%	-9.19%
DMCC	64 Neutral	₹7.53B	26.98	―	0.83%	44.95%	184.17%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
MANGALAM	58 Neutral	₹1.11B	19.78	―	―	-16.39%	-410.09%
SUKHJITS	54 Neutral	₹5.10B	16.37	―	0.61%	1.68%	-41.36%

NGL Fine-Chem Ltd. Corporate Events

NGL Fine-Chem Ltd. Announces Virtual AGM and E-Voting Details

NGL Fine-Chem Ltd. announced the details of its 44th Annual General Meeting (AGM), which will be held virtually on August 19, 2025. The company has provided electronic copies of the AGM notice and annual report to shareholders, emphasizing the use of remote e-voting for resolutions. This move reflects the company’s adaptation to digital processes, potentially enhancing shareholder engagement and operational efficiency.